These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


403 related items for PubMed ID: 3512275

  • 21. Activation of the alternative complement pathway by Leishmania promastigotes: parasite lysis and attachment to macrophages.
    Mosser DM, Edelson PJ.
    J Immunol; 1984 Mar; 132(3):1501-5. PubMed ID: 6363545
    [Abstract] [Full Text] [Related]

  • 22. Complete absence of the third component of complement in man.
    Ballow M, Shira JE, Harden L, Yang SY, Day NK.
    J Clin Invest; 1975 Sep; 56(3):703-10. PubMed ID: 1159084
    [Abstract] [Full Text] [Related]

  • 23. Interaction of soluble C3 fragments with guinea pig lymphocytes. Comparison of effects of C3a, C3b, C3c, and C3d on lymphokine production and lymphocyte proliferation.
    Koopman WJ, Sandberg AL, Wahl SM, Mergenhagen SE.
    J Immunol; 1976 Jul; 117(1):331-6. PubMed ID: 932430
    [Abstract] [Full Text] [Related]

  • 24. Interactions of chrysotile asbestos fibres with the complement system.
    Saint-Remy JM, Cole P.
    Immunology; 1980 Oct; 41(2):431-7. PubMed ID: 6904360
    [Abstract] [Full Text] [Related]

  • 25. Study on C3-like factor in the serum of a C3-deficient subject.
    Kitamura H, Nishimukai H, Sano Y, Nagaki K.
    Immunology; 1984 Feb; 51(2):239-45. PubMed ID: 6693133
    [Abstract] [Full Text] [Related]

  • 26. Classical pathway of complement activation in mammalian kidneys.
    Zwirner J, Felber E, Burger R, Bitter-Suermann D, Riethmüller G, Feucht HE.
    Immunology; 1993 Oct; 80(2):162-7. PubMed ID: 8262545
    [Abstract] [Full Text] [Related]

  • 27. [A congenital deficiency of the C3 fraction of complement. A familial study].
    Sassi F, Bejaoui M, Ayed K.
    Tunis Med; 2003 May; 81(5):354-8. PubMed ID: 12934459
    [Abstract] [Full Text] [Related]

  • 28. The requirement of specific anticapsular IgG for killing of Haemophilus influenzae by the alternative pathway of complement activation.
    Tarr PI, Hosea SW, Brown EJ, Schneerson R, Sutton A, Frank MM.
    J Immunol; 1982 Apr; 128(4):1772-5. PubMed ID: 6977569
    [Abstract] [Full Text] [Related]

  • 29. Complexes between C1q and C3 or C4: novel and specific markers for classical complement pathway activation.
    Wouters D, Wiessenberg HD, Hart M, Bruins P, Voskuyl A, Daha MR, Hack CE.
    J Immunol Methods; 2005 Mar; 298(1-2):35-45. PubMed ID: 15847795
    [Abstract] [Full Text] [Related]

  • 30. IgG and complement-mediated tissue damage in the absence of C2: evidence of a functionally active C2-bypass pathway in a guinea pig model.
    Wagner E, Platt JL, Howell DN, Marsh HC, Frank MM.
    J Immunol; 1999 Sep 15; 163(6):3549-58. PubMed ID: 10477630
    [Abstract] [Full Text] [Related]

  • 31. C3 metabolism in a patient with deficiency of the second component of complement (C2) and discoid lupus erythematosus.
    Wild JH, Zvaifler NJ, Müller-Eberhard HJ, Wilson CB.
    Clin Exp Immunol; 1976 May 15; 24(2):238-48. PubMed ID: 1084239
    [Abstract] [Full Text] [Related]

  • 32. Trypsin-activated complex of human factor B with cobra venom factor (CVF), cleaving C3 and C5 and generating a lytic factor for unsensitized guinea pig erythrocytes. I. Generation of the activated complex.
    Miyama A, Kato T, Horai S, Yokoo J, Kashiba S.
    Biken J; 1975 Dec 15; 18(4):193-204. PubMed ID: 1218074
    [Abstract] [Full Text] [Related]

  • 33. Studies on the haemolytic activity of circulating C1q-C3/C4 complexes.
    Wouters D, Brouwer MC, Daha MR, Hack CE.
    Mol Immunol; 2008 Apr 15; 45(7):1893-9. PubMed ID: 18054386
    [Abstract] [Full Text] [Related]

  • 34. [Formation of classical C3 convertase during the alternative pathway of human complement activation].
    Kozlov LV, Shibanova ED, Zinchenko AA.
    Biokhimiia; 1987 Apr 15; 52(4):660-6. PubMed ID: 3647798
    [Abstract] [Full Text] [Related]

  • 35. A complement C3 fragment equivalent to mammalian C3d from the common carp (Cyprinus carpio): generation in serum after activation of the alternative pathway and detection of its receptor on the lymphocyte surface.
    Nakao M, Miura C, Itoh S, Nakahara M, Okumura K, Mutsuro J, Yano T.
    Fish Shellfish Immunol; 2004 Feb 15; 16(2):139-49. PubMed ID: 15123318
    [Abstract] [Full Text] [Related]

  • 36. Studies of the mechanism of bacterial resistance to complement-mediated killing. V. IgG and F(ab')2 mediate killing of E. coli 0111B4 by the alternative complement pathway without increasing C5b-9 deposition.
    Joiner KA, Goldman RC, Hammer CH, Leive L, Frank MM.
    J Immunol; 1983 Nov 15; 131(5):2563-9. PubMed ID: 6355296
    [Abstract] [Full Text] [Related]

  • 37. Which complement assays and typings are necessary for the diagnosis of complement deficiency in patients with lupus erythematosus? A study of 25 patients.
    Boeckler P, Meyer A, Uring-Lambert B, Goetz J, Cribier B, Hauptmann G, Lipsker D.
    Clin Immunol; 2006 Nov 15; 121(2):198-202. PubMed ID: 16987709
    [Abstract] [Full Text] [Related]

  • 38. The activation of C5 in the fluid phase and in the absence of C3 through the classical pathway of the complement system.
    Kitamura H, Tsuboi M, Nagaki K.
    Immunology; 1986 Jul 15; 58(3):459-65. PubMed ID: 3733147
    [Abstract] [Full Text] [Related]

  • 39. Role of antibody and complement in the immune clearance and destruction of erythrocytes. II. Molecular nature of IgG and IgM complement-fixing sites and effects of their interaction with serum.
    Schreiber AD, Frank MM.
    J Clin Invest; 1972 Mar 15; 51(3):583-9. PubMed ID: 4622104
    [Abstract] [Full Text] [Related]

  • 40. Macrophage-bound C3 fragments as adhesion molecules modulate presentation of exogenous antigens.
    Erdei A, Köhler V, Schäfer H, Burger R.
    Immunobiology; 1992 Aug 15; 185(2-4):314-26. PubMed ID: 1452208
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 21.